Public market insider net selling at Diagnos (V:ADK)

Tristram Coffin, a 10% Holder, acquired 115,000 Common Shares on a direct ownership basis at prices ranging from $0.500 to $0.520 between October 23rd and 26th, 2020. The insider also disposed of 3,000,000 Common Shares on an indirect ownership basis for registered holder 9071-8776 Quebec Inc. at prices ranging from $0.500 to $0.510 also between October 23rd and 26th, 2020. This represents a $1,450,925 net divestment of the company's shares and an account share holdings change of -61.6%.

Marc-André Massue, CFO, disposed of 30,000 Common Shares on a direct ownership basis at prices ranging from $0.510 to $0.520 on October 23rd, 2020. This represents a $15,450 divestment of the company's shares and an account share holdings change of -54.5%.

Diagnos is in the Software Sub Industry Group under the Technology Sector.

DIAGNOS Inc. provides data mining and interpretation consulting services, and designs data analytics software products. The Company operates through two segments: Healthcare and Natural resources. Its Healthcare segment offers image analysis services through Computer Assisted Retinal Analysis (CARA), a software tool, which assists health specialists in the detection of diabetic retinopathy. CARA is a hosted Web-based application that integrates fundus cameras with an image processing engine over an Internet connection. Its Natural resources segment offers data mining consulting services through Computer Aided Resource Detection System (CARDS), a software tool used to assist exploration companies in identifying mining deposits. In addition, it offers project management services. The Company operates in Canada, the United Arab Emirates, India, Mexico, Switzerland, the United States, Poland and Colombia. Diagnos Inc. (ADK) has a high amount of executive buying compared to its micro-cap peers in the market over the past three months. According to regulatory filings yesterday, two insiders have divested a net amount of $1,466,375.